Senores Pharmaceuticals expands US footprint with Roflumilast ANDA acquisition
Senores Pharmaceuticals Limited has taken a significant step in its US expansion strategy by acquiring an Abbreviated New Drug Application (ANDA) for Roflumilast 250 mcg ... Read More
Natco Pharma gets FDA approval for Carfilzomib Vials ANDA
Natco Pharma Limited said that its marketing partner - Breckenridge Pharmaceutical Inc. (BPI), has secured approval from the US Food and Drug Administration (FSA) for ... Read More
Towa Pharmaceutical acquires Pensa Investments from Esteve
Japanese pharma company Towa Pharmaceutical has wrapped up its previously announced €320 million acquisition of Pensa Investments - the generics division of Spanish pharma company ... Read More